Retrospective Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Dec 26, 2023; 11(36): 8447-8457
Published online Dec 26, 2023. doi: 10.12998/wjcc.v11.i36.8447
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Distribution of metastatic foci and mean SUVmax. SUV: Standardised uptake value.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Rate of response to chemotheraphy.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Illustrates the metabolic relationship between F-2-fluoro-2-deoxyglucose and cancer cells. D-glucose: The d-isomer of Glucose is d-glucose; Gluc-GP: Glucose- Glycogen phosphorylase (GP); FDG-GP: F-2-fluoro-2-deoxyglucose - Glycogen phosphorylase (GP); FDG: F-2-fluoro-2-deoxyglucose.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Role of molecular imaging in oncology. IGRT: Image-Guided Radiation Therapy.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Shows the relationship between F-2-fluoro-2-deoxyglucose and tumor cells. A: Molecular imaging targets in oncology; B: Relationship between the death of tumor cells – number of viable tumor cells and F-2-fluoro-2-deoxyglucose positron emission tomography. FDG: Fluorodeoxyglucose; FLT1: Fms-related tyrosine kinase 1; FRGD: frgD gene; F Annexin V: 18F using N-succinimidyl-4-18F-fluorobenzoic acid; Cu-ATSM: Copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone.